Australia's great e-health vision continues to stall with new research showing that greater use of ICT in the health sector could generate savings worth more than $1.5 billion per annum.

The National Blood Authority has refreshed its IT infrastructure to cope with the increasing complexity of supply.

The research community is becoming more sophisticated in the way they approach intellectual property and industry partnerships. Ruth Beran looks at how technology transfer has changed, where it is going and the challenges it faces.

Biotechnology has provided a solution to the problem of how to get science to the market without compromising research, writes editor-in-chief Iain Scott.

Kiran Mazumdar-Shaw told AusBiotech 2005 about opportunities for Australian biotech to work with India.

US venture capitalist Osagie Imasogie told AusBiotech 2005 that biotech companies need to get aggressive when it comes to finding opportunities.

Pfizer's Peter Corr told the AusBiotech 2005 conference that big pharma and biotech are part of a delicate ecosystem -- and both have key roles to play.

The latest medical technology is all very well - if you can afford it. Susan Williamson looks at how one Australian group is coming up with practical healthcare solutions for the developing world.

Should Australia lift its ban on therapeutic cloning? Few topics in Australian science have generated such strong opinions. Ruth Beran reports.

The Australian Stock Exchange has created a market that attracts not only local biotechnology companies, but also gives opportunities to foreign companies that would be unable to attract capital in their own markets. Helen Schuller reports.